Author: Al-Gabri, Naif A; Saghir, Sultan A M; Al-Hashedi, Sallah A; El-Far, Ali H; Khafaga, Asmaa F; Swelum, Ayman A; Al-wajeeh, Abdullah S; Mousa, Shaker A; Abd El-Hack, Mohamed E; Naiel, Mohammed A E; El-Tarabily, Khaled A
Title: Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review Cord-id: 00ba323t Document date: 2021_7_27
ID: 00ba323t
Snippet: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic
Document: As a crucial organ, the lung is exposed to various harmful agents that may induce inflammation and oxidative stress, which may cause chronic or acute lung injury. Nigella sativa, also known as black seed, has been widely used to treat various diseases and is one of the most extensively researched medicinal plants. Thymoquinone (TQ) is the main component of black seed volatile oil and has been proven to have antioxidant, anti-inflammatory, and antineoplastic properties. The potential therapeutic properties of TQ against various pulmonary disorders have been studied in both in vitro and in vivo studies. Furthermore, the application of nanotechnology may increase drug solubility, cellular absorption, drug release (sustained or control), and drug delivery to lung tissue target sites. As a result, fabricating TQ as nanoparticles (NPs) is a potential therapeutic approach against a variety of lung diseases. In this current review, we summarize recent findings on the efficacy of TQ and its nanotypes in lung disorders caused by immunocompromised conditions such as cancer, diabetes, gastric ulcers, and other neurodegenerative diseases. It is concluded that TQ nanoparticles with anti-inflammatory, antioxidant, antiasthma, and antitumor activity may be safely applied to treat lung disorders. However, more research is required before TQ nanoparticles can be used as pharmaceutical preparations in human studies.
Search related documents:
Co phrase search for related documents- acute ards respiratory distress syndrome and liver cirrhosis: 1, 2
- acute ards respiratory distress syndrome and local administration: 1
- acute ards respiratory distress syndrome and low density: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and low density lipoprotein: 1
- acute ards respiratory distress syndrome and low toxicity: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lps dependent: 1, 2, 3
- acute ards respiratory distress syndrome and lps induce: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and lps induce ards: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lps inhaled: 1
- acute ards respiratory distress syndrome and lps intratracheal instillation: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lung antioxidant: 1, 2
- acute ards respiratory distress syndrome and lung disease prevent: 1, 2
- acute ards respiratory distress syndrome and lung disease treat: 1, 2
- acute ards respiratory distress syndrome and lung disease treat prevent: 1, 2
- acute ards respiratory distress syndrome and lung fibrosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39
- acute ards respiratory distress syndrome and lung injury attenuate: 1, 2, 3, 4, 5, 6, 7
- acute ards respiratory distress syndrome and lung injury type: 1, 2, 3, 4
- acute ards respiratory distress syndrome and lung perfusion: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- acute ards respiratory distress syndrome and lung tissue area: 1
Co phrase search for related documents, hyperlinks ordered by date